- ►diabetesjournals.org N Kleefstra, ST Houweling, SJL Bakker, S … - Diabetes Care, 2007 - Am Diabetes Assoc OBJECTIVE—Chromium treatment has been reported to improve glycemic control in patients
with type 2 diabetes. However, concern exists about the possible toxic effects of chromium
picolinate. The aim of this study was to determine the effect of chromium treatment in the ... Cited by 12 - Related articles - BL Direct - All 8 versions
J Racek, L Trefil, D Rajdl, V Mudrova, D Hunter, V … - Biological trace element …, 2006 - Springer 1 Institute of Clinical Biochemistry and Hematology, Charles University, Medical Faculty in
Pilsen, Czech Republic; 2 Dieko, sro, Pilsen, Czech Republic; and 3 Pharma Nord, Vejle, Denmark ... Received April 1, 2005; Revised August 30, 2005; Accepted September 20, 2005 Cited by 11 - Related articles - BL Direct - All 5 versions
D Pei, CH Hsieh, YJ Hung, JC Li, CH Lee, SW Kuo - Metabolism, 2006 - Elsevier The aim of this study is to evaluate the effect and safety of chromium-containing milk powder
in patients with type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial
was conducted in Taiwan. A total of 60 patients with type 2 diabetes mellitus, aged 30 to ... Cited by 6 - Related articles - All 17 versions
- ►diabetesjournals.org N Kleefstra, ST Houweling, FGA Jansman, KH … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In this 6-month double-blind study, patients with an
HbA 1c (A1C) >8% and insulin requirements of >50 units/day were randomly assigned to receive
treatment with placebo or 500 or 1,000 μg chromium daily in the form of chromium ... Cited by 35 - Related articles - BL Direct - All 9 versions
- ►diabetesjournals.org EM Balk, A Tatsioni, AH Lichtenstein, J Lau, AG … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—Forty-one studies met criteria, almost half of which were of poor quality. Among participants
with type 2 diabetes, chromium supplementation improved glycosylated hemoglobin levels by
−0.6% (95% CI −0.9 to −0.2) and fasting glucose by −1.0 mmol/l (−1.4 to −0.5) but not ... Cited by 23 - Related articles - BL Direct - All 13 versions
M Vrtovec, B Vrtovec, A Briski, A Kocijancic, RA … - American Heart Journal, 2005 - Elsevier Although baseline QTc interval was similar in both groups (422 ± 34 milliseconds in group A
vs 425 ± 24 milliseconds in group B, P = .77), QTc interval at 3 months was shorter in group A
(406 ± 35 milliseconds) than in group B (431 ± 26 milliseconds, P = .01). In the following 3 ... Cited by 13 - Related articles - All 23 versions
B Boshtam, M Rafiei, ID Golshadi, M Ani, Z … - … Journal for Vitamin …, 2005 - 万方数据资源系统 This triple-blind, placebo-controlled clinical trial was conducted to determine the effect of the
vitamin E on fasting blood sugar (FBS), serum insulin, and glycated hemoglobin (GHb) in type
11 diabetic patients (NIDDM). A total of 100 patients, with no complications, aged 20-60 ... Cited by 5 - Related articles - BL Direct - All 4 versions
- ►jpgmonline.com F Jinlin, W Binyou, C Terry - Journal of Postgraduate Medicine, 2009 - Medknow Type 2 diabetes mellitus (T2DM) is a polygenetic disorder resulting from interaction of both hereditary
and environmental factors. Diet is an important environmental factor in the development of
T2DM. However, there existed inconsistent conclusions among previous studies. The ... Cited by 5 - Related articles - Cached - All 4 versions
SK Jain, P Patel, K Rogier, SK Jain - Antioxidants & Redox Signaling, 2006 - liebertonline.com C HROMIUM IS AN ESSENTIAL nutrient required for glucose and lipid metabolism (2, 29). Various
studies have re- ported lower levels of chromium in the blood, lenses, and urine of diabetic patients
compared with those of the normal popula- tion (8, 9, 21, 24). Clinical trials have ... Cited by 8 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org J Martin, ZQ Wang, XH Zhang, D Wachtel, J … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Thirty-seven subjects with type 2 diabetes were
evaluated. After baseline, subjects were placed on a sulfonylurea (glipizide gastrointestinal therapeutic
system 5 mg/day) with placebo for 3 months. Subjects were then randomized in a double- ... Cited by 50 - Related articles - BL Direct - All 9 versions
